MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR … – GlobeNewswire (press release)
|
MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR …
GlobeNewswire (press release) GERMANTOWN, Md., March 19, 2018 (GLOBE NEWSWIRE) — Orgenesis Inc. (Nasdaq:ORGS), a manufacturer, service provider and developer of advanced cell therapies, today announced that its manufacturing subsidiary, MaSTherCell S.A. (“MaSTherCell”) was … |
|
MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR …
GlobeNewswire (press release) GERMANTOWN, Md., March 19, 2018 (GLOBE NEWSWIRE) — Orgenesis Inc. (Nasdaq:ORGS), a manufacturer, service provider and developer of advanced cell therapies, today announced that its manufacturing subsidiary, MaSTherCell S.A. (“MaSTherCell”) was … |
Genetic Literacy Project |
FDA puts clinical hold on Biosciences gene therapy trial for Duchenne muscular dystrophy over toxicity concerns
Genetic Literacy Project Concerns over the dosing of patients in IGNITE DMD led to gene therapy pioneer James M. Wilson, M.D., Ph.D., resigning from Solid’s Scientific Advisory Board. According to an amended IPO filing, Dr. Wilson’s resignation followed “emerging concerns … |
Fortune |
Doctors Say They’ve Found a ‘Game Changing’ Stem Cell Treatment for MS
Fortune Interim results from an international trial of a stem cell transplant treatment showed a much higher success rate than the control group, which received a drug treatment. MS is a disease that affects the brain, spinal cord, and immune system, leading … Stem cell transplant ‘game changer’ for MS patients – BBC NewsBBC News Stem cell treatment offers new hope for multiple sclerosis patientsTelegraph.co.uk Stem cell treatment for multiple sclerosis hailed as ‘game-changer’The Times Tech Times –Alphr all 14 news articles » |